Guselkumab in the treatment of patients with plaque psoriasis of moderate and severe severity: Efficacy and safety of interleukin-23 blockade

Guselkumab in the treatment of patients with plaque psoriasis of moderate and severe severity: Efficacy and safety of interleukin-23 blockade

Materials and methods. In this paper, we review publications on the significance of interleukin-(IL)-23 in the pathogenesis of plaque psoriasis and analyse the results of the 1st and 2nd phase clinical studies, as well as the 3rd phase comparative studies VOYAGE 1, VOYAGE 2, NAVIGATE and ECLIPSE on...

Full description

Bibliographic Details
Main Author: V. V. Chikin
Format: Article
Language:English
Published: State Scientific Center of Dermatovenereology and Cosmetology 2020-01-01
Series:Vestnik Dermatologii i Venerologii
Subjects:
plaque psoriasis
p19 subunit
interleukin-23
guselkumab
Online Access:https://www.vestnikdv.ru/jour/article/view/535

Similar Items

Similar Items